CD91:XETRA:XETRA-Amundi Index Solutions - Amundi NYSE Arca Gold BUGS UCITS ETF USD Distributing (EUR)

ETF | Others |

Last Closing

USD 25.95

Change

0.00 (0.00)%

Market Cap

USD 0.28B

Volume

6.05K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-01 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.36 (-0.68%)

USD 446.30B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.12 (-0.72%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.06 (-0.22%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.09 (-0.30%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.12 (-0.47%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

-0.50 (-0.35%)

USD 102.09B
JARI:XETRA Amundi Index Solutions - Amund..

-0.11 (-0.23%)

USD 101.20B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.41 (-0.76%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.20 (-0.19%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-0.34 (-0.06%)

USD 80.38B

ETFs Containing CD91:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain 24.70% 80% B- 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 24.70% 80% B- 79% B-
Trailing 5 Years  
Capital Gain 20.98% 51% F 55% F
Dividend Return 4.34% 20% F 16% F
Total Return 25.31% 50% F 53% F
Average Annual (5 Year Horizon)  
Capital Gain 1.93% 33% F 35% F
Dividend Return 2.18% 34% F 35% F
Total Return 0.24% 30% F 19% F
Risk Return Profile  
Volatility (Standard Deviation) 17.69% 25% F 38% F
Risk Adjusted Return 12.30% 27% F 30% F
Market Capitalization 0.28B 52% F 47% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.